Hospimax

What Hospimax does

Hospimax Healthcare Private Limited is a New Delhi-based, privately held healthcare distribution and marketing company founded in 2005 that operates across three integrated lines of business. First, it serves as the Indian institutional distributor and service partner for a roster of international medical device manufacturers — Draeger (ventilators, anesthesia workstations, patient monitors), Echosens (FibroScan liver elastography), Fresenius Kabi, Werfen/Instrumentation Laboratory (point-of-care diagnostics), Spacelabs Healthcare, ZOLL Medical (defibrillators), Hocoma/DIH and Motek (neuro-rehabilitation robotics), Smiths Medical, and Helmier — covering critical care, hepatology, neuro-rehabilitation, and emergency medicine categories. Second, Hospimax markets a branded pharmaceutical formulations portfolio of roughly 40 SKUs focused on nephrology, immunology, and organ transplantation, spanning immunosuppressants (Suregraft, FujiGraf, Grafsporin, Ceptimmun), renal anemia, CKD-MBD, anti-infectives, hyperkalemia, and cardio-diabetic therapies. Third, the company runs an institutional business acting as distributor and liaison agent for multinational pharma and device principals in Indian government and corporate hospital procurement, handling the full tender lifecycle from formulary introduction and bid preparation through order execution, payment recovery, and EMD return via direct field sales, GEM portal participation, and full-cycle tender representation.

The company makes money through medical device sales and service contracts (hardware sales revenue), tender-based transaction fees and commissions on institutional procurement, branded pharmaceutical sales to hospitals, institutions, nursing homes, and retail pharmacies, and professional services revenue from biomedical engineering support across a 50-engineer technical team. Its customer base is concentrated in central and state government healthcare institutions — DHCL/CPA Delhi, AIIMS, Safdarjung, Dr. RML, DGAFMS, PGIMER, GMCH, IGMC, NACO, ESIC, World Bank-funded projects through RITES/SAMS/CMSS/HITES, and state Medical Services Corporations across Punjab, Haryana, and Rajasthan — with newer expansion into corporate hospital pharmacy chains and direct-to-patient services for chronic disease management and transplantation. Operations are supported by a cold-chain-equipped warehouse and field offices across New Delhi, Mumbai, Chennai, Bangalore, Kolkata, Vizag, Jalandhar, and Ludhiana, with pricing not publicly disclosed and no external funding rounds on record.

Name

Hospimax

Legal name

Hospimax Healthcare Private Limited

Website

https://hospimax.com

Company type

Private

Founded year

2005

Operating status

Operating

Headcount range

101–250 employees

Short description

Hospimax Healthcare is a New Delhi-based distributor (founded 2005) representing international medical device makers (Draeger, Echosens, Hocoma, ZOLL, Werfen) and marketing a 40-SKU branded pharma portfolio in nephrology and transplantation, supplying Indian government hospitals, state procurement agencies, and corporate hospital chains via tender-based field sales.

Ownership category

akta.pro rank

Product category

Medical Device & Pharmaceutical Distribution

NAICS

Drugs and Druggists' Sundries Merchant Wholesalers (42421), Pharmaceutical and Medicine Manufacturing (3254)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047), Pharmaceutical Preparations (2834)

akta.pro primary industry

Nephrology & Urology Specialty Pharmaceuticals (HLAIACAH)

akta.pro secondary industries

Transplant & Immunosuppression Specialty Pharmaceuticals (HLAIACAJ), Specialty Pharma & Biologics Distribution (GDP-compliant) (HLAGAMAD), Specialty Pharmacy & Complex Therapy Management Platforms (HLACAKAG)

Keywords

• Medical device distribution
• Pharmaceutical formulations
• Hospital procurement services
• Nephrology therapeutics
• Government healthcare supply

Headquarters

HQ city

New Delhi

HQ country

India

HQ region

Asia

Offices3 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Supply Chain, Marketing or Sales, Infrastructure, Technology or R&D

Revenue model

1. Medical Devices Distribution: Distribution and representation of international medical device brands (Echosens, Draeger, Fresenius Kabi, Instrumentation Laboratory/Werfen, Helmier, Spacelabs, ZOLL Medical, DIH Medical-Hocoma) across government, corporate, and private hospitals in India. Revenue generated through product sales, service contracts, and commission arrangements.
2. Institutional and Government Tenders: Participation in government and institutional procurement through tender processes (e-tendering, GEM portal). Acts as distributor and liaison agent covering the full procurement lifecycle from bid preparation to order execution and payment recovery.
3. Branded Formulations (Pharmaceuticals): Launch of branded generic formulations in Nephrology, Immunology, and Organ Transplantation therapeutic areas. Products include immunosuppressives (Suregraft, FujiGraf, Grafsporin, Ceptimmun), CKD management drugs, renal anemia treatments, and supportive therapies. Revenue through pharmaceutical sales to hospitals, institutions, nursing homes, and retail pharmacies.
4. Technical Services and Support: Rendering reliable services for various medical device modalities through a team of biomedical engineers, including pre-sales and post-sales technical support, product training, and troubleshooting.

Go-to-market motion3 records

Distribution channels4 records

Marketing channels5 records

Core offering

Hospimax Healthcare Private Limited distributes international medical devices and sells its own branded pharmaceutical formulations focused on nephrology, immunology, and organ transplantation to government hospitals, corporate hospital chains, and procurement agencies across India. The company also acts as a liaison agent and distributor for multinational pharma and medical device principals, providing end-to-end procurement services including tender participation, bid preparation, order execution, and payment recovery. Its product portfolio spans critical care equipment, hepatology diagnostics, neuro-rehabilitation robotics, and a comprehensive therapy range covering transplantation immunosuppressants, renal anemia, CKD-MBD, anti-infectives, and cardio-diabetic segments.

Product overview

Hospimax is a healthcare company operating since 2005 with a dual business model comprising medical devices and branded pharmaceutical formulations. The medical devices portfolio includes critical care equipment (ventilators, infusion pumps, patient monitors, blood warmers from Draeger, Smiths Medical, ZOLL Medical, Werfen), hepatology diagnostics (Fibroscan liver elastography devices from Echosens), and neuro-rehabilitation robotics (Lokomat, CAREN, C-Mill, RYSEN from Hocoma and MOTEK). The formulations business spans six therapeutic segments: transplantation immunosuppressants (Suregraft, FujiGraf, Grafsporin, Ceptimmun), renal anemia management (Dpoetin, Feroneph, Fesomalt), CKD-MBD (Phosdip, SobiMax, Nefmax-CT), anti-infectives (Fenemor, Fosbiotic), hyperkalemia (PotbloK), and cardio-diabetic care (Nefdapa, HosVilda, CoQTrust). Additionally, the company provides institutional business services for government and corporate hospital procurement, covering the full tender lifecycle from product introduction to execution. The three core offerings work together: medical devices enable diagnosis and treatment, formulations provide pharmaceutical therapy across chronic kidney disease stages from CKD to ESRD and transplantation, and institutional services facilitate procurement for healthcare institutions.

Differentiator

Problem solved

Functional benefit

Brands

• Suregraft: Transplantation formulation product
• FujiGraf
• Grafsporin
• Ceptimmun
• Ceptimmun-S
• ValgaMax 450
• Dpoetin
• Feroneph
• Feroneph-O
• Fesomalt
• Feroneph-LP
• Fesocarb
• Ursogrip
• Nefcarnit-E
• Megpro
• Pospondyl
• Detoxiren
• Evacusoft
• Amiseven 7%
• Nefmax-MV
• Alcysta
• CoQMulti
• Nefcarnit Injection
• Alcysta-600 EF
• Oxalfree
• Phosdip
• Hosvit-D 60K
• Phosphout
• Nefmax-CT
• SobiMax
• Oshecad-CT
• Oshecad
• Cinapath
• Fenemor 200
• Fosbiotic
• Mannocran
• PotbloK
• CoQTrust
• Nefdapa
• HosVilda
• Hosvilda-M
• Hoslina-5
• Hoslina-M
• Hoslina-D
• Glugrip
• SacuAct
• FibroScan
• MiniPlus 430

Products and services

• Critical Care Medical Devices Critical care equipment portfolio including ICU ventilators (Draeger Savina 300, EVITA V600/V800), multi-parameter patient monitors (VISTA 120), anesthesia workstations (ATLAN FAMILY, Fabius Plus XL), and gas monitoring modules (SCIO AGM) distributed to government and corporate hospitals in India.
• Infusion Care and Blood/Fluid Warming Devices Ambulatory infusion pumps (CADD Legacy, CADD Solis), syringe pumps (Graseby 2000), high-flow nasal oxygenation (O2FLO HFNO), blood and fluid warmers (Level 1 Hotline, H1200), portable ventilators (Parapac Plus), and neonatal transport ventilators (babyPAC) for hospital infusion therapy and critical care.
• Point-of-Care Diagnostic Equipment Critical care analyzers including GEM 3000 and GEM 4000 blood gas/electrolyte systems, ROTEM thromboelastometry for coagulation testing, and ACL Elite Pro hemostasis analyzer distributed to hospitals across India.
• Emergency Resuscitation Devices Automated external defibrillators (ZOLL AED Plus and AED 3) with real-time CPR feedback for emergency cardiac care response across Indian healthcare institutions.
• Hepatology Diagnostic Devices (FibroScan) Non-invasive liver elastography systems from Echosens (France) including MiniPlus 430, Fibroscan 430 mini+, Fibroscan 530 Compact, and Fibroscan 630 Expert for liver fibrosis and fatty liver detection, distributed to hepatology and gastroenterology departments across India.
• Neuro-Mobility Rehabilitation Devices Advanced robotic rehabilitation equipment including Hocoma Lokomat Nanos, Lokomat Pro, Andago, ERIGO, ArmeoSpring Pro; Motek CAREN, C-Mill, and RYSEN; plus SpineMed spinal decompression devices, distributed to neuro-rehabilitation hospitals and physiotherapy clinics in India.
• Transplantation Immunosuppressive Formulations Branded generic immunosuppressive medications including Suregraft, FujiGraf, Grafsporin, Ceptimmun, Ceptimmun-S, and ValgaMax 450 for organ transplantation (kidney, liver, heart, lung, bone marrow) and autoimmune disease management.
• Renal Anemia Management Formulations Erythropoiesis-stimulating agents and iron supplements including Dpoetin, Feroneph, Feroneph-O, Fesomalt, Feroneph-LP, and Fesocarb for chronic kidney disease anemia correction.
• CKD-MBD Management Formulations Phosphate binders, vitamin D analogs, and calcimimetics including Phosdip, Hosvit-D 60K, Phosphout, Nefmax-CT, SobiMax, Oshecad-CT, Oshecad, and Cinapath for chronic kidney disease-mineral bone disorder management.
• Supportive Therapy Formulations Nutritional supplements, citicoline, L-carnitine, and adjunctive therapies including Ursogrip, Nefcarnit-E, Megpro, Pospondyl, Detoxiren, Evacusoft, Amiseven 7%, Nefmax-MV, Alcysta, CoQMulti, Nefcarnit Injection, Alcysta-600 EF, and Oxalfree for renal, hepatic, and neurological supportive care.
• Anti-Infective Formulations Antimicrobial and probiotic formulations including Fenemor 200, Fosbiotic, and Mannocran for infectious complications and urinary tract infections in renal and urology patients.
• Hyperkalemia Management Formulations Potassium binder formulation PotbloK for hyperkalemia management in chronic kidney disease patients.
• Cardio-Diabetic Formulations CoQ10 and antidiabetic medications including CoQTrust, Nefdapa, HosVilda, Hosvilda-M, Hoslina-5, Hoslina-M, Hoslina-D, Glugrip, and SacuAct for cardiovascular and diabetic kidney disease management.
• Institutional Government Tender and Procurement Services End-to-end procurement and tender representation services for government healthcare institutions, autonomous bodies, and procurement agencies (DHCL/CPA, AIIMS, DGAFMS, state medical services corporations, GEM portal) including bid preparation, order execution, and payment recovery. Also serves as liaison agent and distributor for multinational pharma and medical device principals seeking Indian market access.
• Biomedical Engineering Technical Services and Support Pre-sales and post-sales technical support, equipment servicing, maintenance, troubleshooting, and product training for medical device modalities, delivered through a team of 50 biomedical engineers with specialization in critical care, hepatology, neuro rehabilitation, and diagnostics.

Named customers13 records

Segments5 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Ten partnerships are on record, tiered core and major.

• Echosens (France)coreTechnology or IntegrationEchosens, a French company, is a key partner for FibroScan non-invasive liver diagnostics. Hospimax distributes and services FibroScan products including MiniPlus 430, Fibroscan 430 mini+, Fibroscan 530 Compact, and Fibroscan 630 Expert for liver fibrosis and fatty liver detection across Indian institutions.
• Draeger (Germany)coreTechnology or IntegrationDraeger, a German medical technology company, supplies ICU ventilators (Savina 300, EVITA V600/V800), patient monitors (VISTA 120), and anesthesia workstations (ATLAN FAMILY, Fabius Plus XL) distributed and serviced by Hospimax in India.
• Fresenius Kabi (India)coreTechnology or IntegrationFresenius Kabi India is a key pharmaceutical and medical device partner represented by Hospimax for critical care and hospital product supply in Indian institutional markets.
• Instrumentation Laboratory, a Werfen company (Spain)coreTechnology or IntegrationInstrumentation Laboratory (now part of Werfen group, Spain) supplies critical care diagnostic equipment including GEM 3000, GEM 4000, ROTEM coagulation analyzers, and ACL Elite Pro distributed by Hospimax in India.
• Helmier (India)coreChannel Partner/ Reseller/ DistributorHelmier India supplies medical devices including HFNO O2FLO high-flow nasal oxygen systems and Graseby syringe pumps distributed through Hospimax's institutional network in India.
• Spacelabs Healthcare (USA)majorTechnology or IntegrationSpacelabs Healthcare, a US-based medical device company, partners with Hospimax for patient monitoring and diagnostic solutions distributed in Indian government and corporate hospital markets.
• ZOLL Medical Inc (USA)coreTechnology or IntegrationZOLL Medical, a US company, supplies emergency resuscitation devices including AED Plus and AED 3 automated external defibrillators distributed and serviced by Hospimax across Indian healthcare institutions.
• DIH Medical – Hocoma (Switzerland)coreTechnology or IntegrationDIH Medical's Hocoma division (Switzerland) supplies advanced neuro robotic rehabilitation devices including Lokomat Nanos, Lokomat Pro, Andago, ERIGO, and ArmeoSpring Pro distributed by Hospimax in India.
• Motek (Netherlands)majorTechnology or IntegrationMotek supplies CAREN (Computer Assisted Rehabilitation Environment), C-Mill treadmill, and RYSEN rehabilitation devices distributed by Hospimax for neuro mobility rehabilitation in Indian hospitals and clinics.
• Smiths MedicalmajorTechnology or IntegrationSmiths Medical supplies infusion care devices including CADD Legacy, CADD Solis syringe pumps, Level 1 blood and fluid warmers (Hotline, H1200), Parapac Plus, and babyPAC neonatal ventilators distributed by Hospimax.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Mindray Medical India: Indian arm of a global patient monitoring and IVD manufacturer selling critical care and OR equipment through institutional channels. Comparable to Hospimax's Draeger/Spacelabs/Werfen critical care representation model.
• Wipro GE Healthcare: Joint venture distributing GE HealthCare's patient monitoring, anesthesia, and diagnostic imaging portfolio across Indian hospitals. Comparable as a premium international-principal medical device distributor with strong critical care and government hospital presence in India.
• TTK Healthcare: Diversified Indian healthcare group with medical devices distribution and pharma businesses including critical care and hospital supplies. Closely comparable business model to Hospimax's dual device + pharma distribution structure in India.
• B. Braun Medical India: Subsidiary of a global medical device manufacturer with significant Indian operations across infusion therapy, surgical instruments, and critical care. Closely comparable to Hospimax in critical care/infusion pump representation and hospital-channel distribution in India.
• Transasia Bio-Medicals: India's largest in-vitro diagnostics and medical device distributor with a pan-India institutional sales force and representation of multiple international principals. Directly comparable to Hospimax as a multi-principal medical device distributor serving government and corporate hospitals in India.

Broad incumbents

• Biocon: Indian biopharmaceutical company with strong nephrology, diabetology, and biologics franchises (including renal anemia). Comparable to Hospimax's branded nephrology/transplant strategy but with biologic manufacturing capabilities Hospimax lacks.
• Philips India: Indian operations of a global health technology major covering patient monitoring, critical care, and diagnostic equipment. Comparable to Hospimax's Spacelabs/Draeger critical care representation, with significantly larger installed base.
• Bharat Serums and Vaccines: India-focused biotech with portfolio spanning nephrology, critical care, and transplantation therapeutics. Comparable therapy overlap to Hospimax's branded formulations across renal/transplant segments.
• Cipla: Large Indian pharma company with a dedicated nephrology/transplant portfolio and institutional sales force. Overlaps with Hospimax's branded formulation strategy in immunosuppressives and renal therapy but at vastly larger scale and broader therapeutic breadth.
• Siemens Healthineers India: Indian arm of a global medical device and diagnostics major with strong presence in critical care, IVD, and hospital procurement. Comparable in principal-backed critical care and diagnostics distribution but at much greater scale.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Hospimax